Patent Suit Over Generic IBS Drugs Will Go On
West Virginia's top judge on Thursday rejected arguments from the makers of gastrointestinal drug Trulance to hand the companies a win in their effort to assert patents to block several Mylan...To view the full article, register now.
Already a subscriber? Click here to view full article